✦ LIBER ✦

Response to second-line chemotherapy in patients with hormone refractory prostate cancer receiving two sequences of mitoxantrone and taxanes

✍ Scribed by William K. Oh; Judith Manola; Vladana Babcic; Neesha Harnam; Philip W. Kantoff

Book ID: 116945724
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 129 KB
Volume: 67
Category: Article
ISSN: 0090-4295
DOI: 10.1016/j.urology.2006.01.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

First- and second-line chemotherapy with

First- and second-line chemotherapy with docetaxel or mitoxantrone in patients with hormone-refractory prostate cancer : Does sequence matter?

✍ Jorg Michels; Trina Montemurro; Nevin Murray; Christian Kollmannsberger; Kim Ngu 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 1 views

Activity of second-line chemotherapy in

Activity of second-line chemotherapy in docetaxel-refractory hormone-refractory prostate cancer patients : Randomized phase 2 study of ixabepilone or mitoxantrone and prednisone

✍ Jonathan E. Rosenberg; Vivian K. Weinberg; W. Kevin Kelly; Dror Michaelson; Maha 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB 👁 1 views

## Abstract ## BACKGROUND. This randomized, noncomparative, multicenter, clinical trial evaluated ixabepilone or mitoxantrone/prednisone (MP) as second‐line chemotherapy for taxane‐refractory, hormone‐refractory, prostate cancer (HRPC). ## METHODS. Patients with HRPC that progressed during or wi

Response to docetaxel/carboplatin-based

Response to docetaxel/carboplatin-based chemotherapy as first- and second-line therapy in patients with metastatic hormone-refractory prostate cancer

✍ Mari Nakabayashi; Oliver Sartor; Susanna Jacobus; Meredith M. Regan; David McKea 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

Gemcitabine Combined with Oxaliplatin (G

Gemcitabine Combined with Oxaliplatin (GEMOX) as Second-Line Chemotherapy in Patients with Advanced Ovarian Cancer Refractory or Resistant to Platinum and Taxane

✍ Raspagliesi, Francesco; Zanaboni, Flavia; Vecchione, Francesca; Hanozet, Frances 📂 Article 📅 2004 🏛 S. Karger AG 🌐 English ⚖ 101 KB

Glutathione concentration may be a usefu

Glutathione concentration may be a useful predictor of response to second-line chemotherapy in patients with ovarian cancer

✍ Junzo Kigawa; Yukihisa Minagawa; Yasunobu Kanamori; Hiroaki Itamochi; Xiusi Chen 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB 👁 2 views

in tumor samples was determined by immunohistochemical staining and Western blot analysis. GSH concentration was measured by an enzymatic assay. Department of Obstetrics and Gynecology, Tot- ## RESULTS. The response rate was 38.4%. The estimated 3-year survival rate for tori University School of

Topoisomerase-I activity and response to

Topoisomerase-I activity and response to second-line chemotherapy consisting of camptothecin-11 and cisplatin in patients with ovarian cancer

✍ Junzo Kigawa; Masakuni Takahashi; Yukihisa Minagawa; Tetsuro Oishi; Toru Sugiyam 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 108 KB 👁 2 views

The aim of the present study was to clarify the relationship between topoisomerase-I (topo-I) activity and sensitivity to second-line chemotherapy consisting of cisplatin and camptothecin-11 (CPT-11) in patients with ovarian cancer. Thirty Japanese women with relapsed epithelial ovarian cancer who r